Ed Field discovered his passion for building biotechnology innovation while working with an equity-backed biopharma start-up ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

May 30, 2024 — Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic ...

A new technology is poised to transform the discovery of microbial species and enzymes with specific in situ metabolic ...

Jan. 15, 2025 — Scientists have revealed the secret to the structural integrity of tiny particles that transport cargo from cell to cell through blood vessels and bodily fluids: special proteins ...

After hours: January 16 at 5:51:58 PM EST Loading Chart for PBYI ...

Washington, DC [US], January 11 (ANI): US lawmakers and industry leaders are calling for stricter export control regulations to prevent US biopharmaceutical companies from collaborating with China's ...

Animal biotechnology is a branch of biotechnology in which molecular biology techniques are used to genetically engineer (i.e. modify the genome of) animals in order to improve their suitability ...

Nate Anderson, the founder of the muckraking financial information firm Hindenburg Research, says he is disbanding the ...

Stocks are pricey—but there are values to be had. Learn more about our panelists’ picks in this week’s Roundtable installment.

NYSEAM:CATX) Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference ...